openPR Logo
Press release

Trends in the Depression Drugs Market 2017-2027

04-13-2017 02:05 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Future Market Insights

Depression is a serious mood disorder which causes a persistent feeling of sadness and loss of interest thus affecting daily routine activities such as sleeping, walking, talking, thinking, eating etc. depression is different from temporary feeling of sadness. Signs and symptoms of depression includes persistent sadness, irritability, loss of interest in daily routine activities, feelings of worthlessness and pessimism, guilt, social withdrawal, fatigue, insomnia, loss of appetite, headache, cramps, digestive problems, weight changes, restlessness, and suicide attempts however alcoholism and drug abuse may also be the signs of depression. Signs and symptoms of depression vary from person to person depending upon the risk factors and individual thinking and lifestyle. Also there are different forms of depression which has unique character tics such as persistent depressive disorder, perinatal depression disorder, psychotic depression, Seasonal affective disorder and bipolar depression. Depression is also categorised based on its severity as mild, moderate and severe. Psychotic depression, persistent depressive disorder and bipolar disorder are the severe form of depression and should be treated with anti-depressants and psychotherapies. Depression can occur at any age but often initiates in adulthood.

Depression drugs market comprises of the drugs which cures signs and symptoms caused by the depression, these drugs are known as anti-depressants. Anti-depressants includes tricyclic antidepressants, selective serotonin reuptake inhibitors, atypical antidepressants, and monoamine oxidase inhibitors. These drugs are also utilized in the treatment of a number of other mood disorders such as anxiety disorders, eating disorders, and obsessive compulsive disorder.

Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-3290

Depression Drugs Market: Drivers and Restraints

Depression drugs market is growing, this is attributed to increasing prevalence of depression and other mood disorders with increasing availability of various anti-depressants in the market. Factors such as increasing reliance on medications for controlling the symptoms of depression is expected to contribute significantly to the depression drugs market revenue in the near future. In addition to this, growing healthcare expenditure, and rising insurance coverage also aids the growth of depression drugs market as increasing number of relatives of depressive cases are adopting early measures to halt the deterioration process. Also, availability of newer anti-depressants drives the depression drugs market, giving enormous opportunities to the companies within this market. However side effects associated with these drugs along with availability of other treatment methods such as psychotherapy is anticipated to hamper the revenue growth of depression drugs market over the forecast period.

Depression DrugsMarket: Overview

Depression drugs market is expected to grow at a significant rate, over the forecast period. The market is anticipated to perform well over the forecast period attributed to increasing number of patients suffering from mild to moderate depression along with the availability of more drugs in the market. Also the depression drugs market is expanding globally due to increasing distribution partnerships among depression drug manufactures. The Depression Drugs market is expected to grow with a fastest CAGR over the forecast period due to increasing number of pipeline antidepressants. Increasing competition among major companies in the market to develop new formulation drugs which cures more than one symptoms also drives the depression drugs market towards the growth curve.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-3290

Depression Drugs Market: Region-wise Outlook

Depending on geographic region, the depression drugs market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

North America is the largest regional market owing to high patient awareness levels regarding availability of various drugs for depression, rising healthcare expenditure and relatively larger number of R&D exercises pertaining to drug manufacturing and marketing etc. these factors contribute for significant revenue generation from the region.

Asia Pacific excluding Japan is expected to grow at the fastest CAGR because of increasing prevalence of depression and mood disorders in the region along with more focus of the companies to target the markets such as India and China leads to increase in the revenue growth of depression drugs market throughout the forecast period.

Depression Drugs Market: Key Players

Some of the players in depression drugs marketinclude AstraZeneca, GlaxoSmithKline, Merck & Co., SK Biopharmaceuticals, Novartis, Forest Laboratories, Naurex etc. whereas some and regionalplayers also have a significant presence in depression drugs market.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Press: press@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Trends in the Depression Drugs Market 2017-2027 here

News-ID: 500810 • Views: 191

More Releases from Future Market Insights

Ferrovanadium Market to Witness Robust Expansion throughout the Forecast 2018-20 …
Future Market Insights (FMI) analyses the global ferrovanadium market in its new publication titled “Ferrovanadium Market: Global Industry Analysis (2013 – 2017) & Opportunity Assessment (2018 – 2028)”. This study provides data for 2017 along with the forecast for the period (2018–2028). The main objective of the report is to identify the dynamics of the market and provide recent updates and insights pertaining to various segments of the global ferrovanadium
Automotive Lighting Market is expected to grow at a CAGR of ~6% during the forec …
In a recent publication, Future Market Insights (FMI) provides a perspective on the growth trajectory of automotive lighting market for the period between 2019 and 2029. According to the study, worldwide sales of automotive lighting reached ~2 billion units, equating a value of ~US$ 36.5 billion in 2018. Gains remain driven by growing popularity of luxury cars and high purchasing power of middle class demographic in developing countries that increased the
Motorcycle Suspension System Market Size, Share, Industry Analysis, Future Growt …
Future Market Insights has released a new market study on "Motorcycle Suspension System Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028", which studies the global Motorcycle Suspension System market and offers deep dive analysis for the next ten years. The report evaluates all the key macro-economic factors projected to support the growth of the global as well as regional markets. The report on Motorcycle Suspension System also presents the
Clinical Trials Market Survey Report 2021 Along with Statistics, Forecasts till …
The study offers a long-term forecast of the clinical trials landscape for the period between 2019 and 2029. The clinical trials landscape is projected to record a 4.5% CAGR through 2029. Collaboration at Its Peak: Key Strategy of Manufacturers in Clinical Trials Market For reducing economic burden, many companies are planning to shift their focus towards on-core business activities, thereby outsourcing their clinical trials activities to the CROs (contract research organizations). This

All 5 Releases


More Releases for Depression

Portable Depression & Mood Monitoring Market Size
As per the research conducted by GME, the Portable Depression & Mood Monitoring Market will grow with a CAGR value of 10.5 percent. With the increasing cases of depression and anxiety, the market for smart and portable depression & mood monitors is ought to be growing the fastest during the forecast period. Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Portable Depression
Global Anti-Depression Devices & Therapy Market
As per the research conducted by GME, the Anti-Depression Devices & Therapy Market will grow with a high CAGR value over the forecast period. Browse TOC on “Global Anti-Depression Devices & Therapy Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-anti-depression-devices-therapy-market-2993 By Product (Light Therapy, Stimulation Therapies, Electro Stimulator Devices, Helmet Therapy), By Type (Psychotic Depression, Persistent Depressive Disorder, Postpartum Depression, Major Depression, Seasonal Affective Disorder), By End-Use (Hospitals, Homecare Setting, Long Term
Depression Cannot Hit A Moving Target
Cottonwood Heights, Utah, Mar 12, 2020 -- Depression can't hit a moving target. That was a phrase to live by for Chelsea Hansen. She was full of life and love, and she had big goals. But soon she was to discover that life doesn't turn out the way she planned. Behind the Fake Smile is a fictional book based on real-life experiences. It's the story of how Chelsea navigates a world
Depression Drugs Market: Increase in Cases of Depression to Boost Market Growth
Transparency Market Research (TMR) has published a new report titled, “Depression Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global depression drugs market was valued at US$ 6,500 Mn in 2017 and is anticipated to decline at a CAGR of 2% from 2018 to 2026. The report suggests that rise in incidence of major depression disorders is projected to drive
Depression Therapeutics Market Forecast till 2025
Antidepressants are used to treat a wide range of mental disorders, including depression, anxiety, and major depressive disorder. Certain neurotransmitters in the brain exist in chemical form such as dopamine and serotonin, which are responsible for maintaining emotional balance such as mood and behavior. Antidepressants cover a wide range of drug categories, including selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants
Depression Drug Market: Global Depression Drug Forecast Will Reach $16.8 billion …
Zion Market Research has published a new report titled “Depression Drug (Benzodiazepines, SNRIs, TCAs, TeCAs, Atypical Antipsychotics, Monoamine Oxidase inhibitors and Others) Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2020” According to the report, the global depression drug market was valued at USD 14.51 billion in 2014 and is expected to generate revenue of USD 16.8 billion by end of 2020, growing at a CAGR of 2.50%